We have located links that may give you full text access.
Journal Article
Review
The Impact of Obesity on Reproductive Health and Metabolism in Reproductive Age Females.
Fertility and Sterility 2024 May 3
Obesity is a highly prevalent chronic disease that impacts over 40% of reproductive-aged females. The pathophysiology of obesity is complex and can be understood simply as a chronic energy imbalance whereby caloric intake exceeds caloric expenditure with energy surplus stored in adipose tissue. Obesity may be categorized into degrees of severity as well as different phenotypes based on metabolic health and underlying pathophysiology. Obesity and excess adiposity have a significant impact on fertility and reproductive health with direct effects on the hypothalamic-pituitary-ovarian axis, the ovary/oocyte, and the endometrium. There are significant adverse pregnancy outcomes related to obesity and together with excess weight gain prior to, during, and after pregnancy, can alter lifelong risk for metabolically unhealthy obesity. Given the high-prevalence and pervasive impact of obesity on reproductive health, there is a need for better and individualized care for reproductive-aged females that considers obesity phenotype, underlying pathophysiology, and effective and sustainable interventions to treat obesity and manage weight gain prior to, during, and after pregnancy.
Full text links
Related Resources
Trending Papers
The New Challenge of Obesity - Obesity-Associated Nephropathy.Diabetes, Metabolic Syndrome and Obesity 2024
Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials.Advances in Therapy 2024 May 15
Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review.Seminars in Nephrology 2024 May 15
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 2024 April 5
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.Cochrane Database of Systematic Reviews 2024 May 22
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app